Bio Medica Laboratories — an Indore-based parenteral formulations manufacturer with 58 liquid injectable and 15 dry powder injectable products — opens its ₹52.43 Cr NSE SME IPO on May 21, 2026 at ₹132-139 per share. Complete review, GMP, financials and should-you-apply analysis.
IPO Articles & Analysis
Insights, how-to guides, and market updates from the ipomarket.in research team.